The effects of the dietary supplement Cardioflex Q10 on reducing cardiovascular disease risk factors in adults

Thumbnail Image
Kouritzin, Trevor
Journal Title
Journal ISSN
Volume Title
The objective of this study was to determine whether daily supplementation with the multi-ingredient dietary supplement Cardioflex for 90 days would improve cardiovascular disease risk factors in adults aged 30 – 65 years old. A randomized double-blind placebo-controlled parallel clinical study was conducted with 67 participants who received one daily serving (10g) of Cardioflex (n=33) or 10g of an isocaloric maltodextrin placebo (n=34). Plasma lipid profile, anthropometric measures, cardiac measures, inflammatory and endothelial function biomarkers were measured at baseline and endpoint of the study. Analysis of covariance was conducted using SPSS. In this study, heart rate variability (HRV) increased for the Cardioflex group (65.24 ± 9.44 ms to 68.72 ± 9.78 ms) while a decrease (69.95 ± 9.37 ms to 63.68 ± 9.08 ms) was seen in the placebo group, resulting in an overall 6.8 millisecond higher post-treatment HRV in the Cardioflex group (P=0.04). There were no other significant time x group interactions from the Cardioflex treatment. Further research is needed to explore Cardioflex’s potential effects on HRV and other cardiovascular disease risk factors.
Cardiovascular, Supplements, Cardiovascular disease